CI vs CVS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CI is a StrongBuy and CVS is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CI’s FA Score shows that 3 FA rating(s) are green whileCVS’s FA Score has 1 green FA rating(s).
- CI’s FA Score: 3 green, 2 red.
- CVS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CI’s TA Score shows that 4 TA indicator(s) are bullish while CVS’s TA Score has 3 bullish TA indicator(s).
- CI’s TA Score: 4 bullish, 5 bearish.
- CVS’s TA Score: 3 bullish, 7 bearish.
Price Growth
CI (@Managed Health Care) experienced а +5.34% price change this week, while CVS (@Managed Health Care) price change was -11.91% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was -3.20%. For the same industry, the average monthly price growth was -6.48%, and the average quarterly price growth was +18.58%.
Reported Earning Dates
CI is expected to report earnings on Jan 31, 2025.
CVS is expected to report earnings on Feb 05, 2025.
Industries' Descriptions
@Managed Health Care (-3.20% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| CI | CVS | CI / CVS | |
| Capitalization | 103B | 100B | 103% |
| EBITDA | N/A | 18.2B | - |
| Gain YTD | 12.235 | -28.394 | -43% |
| P/E Ratio | 20.94 | 12.33 | 170% |
| Revenue | 195B | 358B | 54% |
| Total Cash | 8.75B | 11.5B | 76% |
| Total Debt | 30.9B | 79.4B | 39% |
CI | CVS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 5 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 25 Undervalued | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 16 | 100 | |
SMR RATING 1..100 | 100 | 66 | |
PRICE GROWTH RATING 1..100 | 54 | 63 | |
P/E GROWTH RATING 1..100 | 14 | 35 | |
SEASONALITY SCORE 1..100 | 50 | 95 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (5) in the Drugstore Chains industry is in the same range as CI (25) in the Managed Health Care industry. This means that CVS’s stock grew similarly to CI’s over the last 12 months.
CI's Profit vs Risk Rating (16) in the Managed Health Care industry is significantly better than the same rating for CVS (100) in the Drugstore Chains industry. This means that CI’s stock grew significantly faster than CVS’s over the last 12 months.
CVS's SMR Rating (66) in the Drugstore Chains industry is somewhat better than the same rating for CI (100) in the Managed Health Care industry. This means that CVS’s stock grew somewhat faster than CI’s over the last 12 months.
CI's Price Growth Rating (54) in the Managed Health Care industry is in the same range as CVS (63) in the Drugstore Chains industry. This means that CI’s stock grew similarly to CVS’s over the last 12 months.
CI's P/E Growth Rating (14) in the Managed Health Care industry is in the same range as CVS (35) in the Drugstore Chains industry. This means that CI’s stock grew similarly to CVS’s over the last 12 months.
| CI | CVS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 48% | 2 days ago 56% |
| Stochastic ODDS (%) | 2 days ago 58% | 2 days ago 64% |
| Momentum ODDS (%) | 2 days ago 67% | 2 days ago 53% |
| MACD ODDS (%) | 2 days ago 52% | 2 days ago 51% |
| TrendWeek ODDS (%) | 2 days ago 61% | 2 days ago 57% |
| TrendMonth ODDS (%) | 2 days ago 60% | 2 days ago 57% |
| Advances ODDS (%) | 4 days ago 64% | 9 days ago 0% |
| Declines ODDS (%) | 2 days ago 62% | 7 days ago 60% |
| BollingerBands ODDS (%) | 2 days ago 65% | 2 days ago 71% |
| Aroon ODDS (%) | 2 days ago 62% | 2 days ago 51% |
CI and
Correlation & Price change
A.I.dvisor tells us that CI and ELV have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CI and ELV's prices will move in lockstep.
CVS and
Correlation & Price change
A.I.dvisor indicates that over the last year, CVS has been loosely correlated with UNH. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CVS jumps, then UNH could also see price increases.
| Ticker / NAME | Correlation To CVS | 1D Price Change % | ||
|---|---|---|---|---|
| CVS | 100% | +0.44% | ||
| UNH - CVS | 38% Loosely correlated | -1.43% | ||
| HUM - CVS | 36% Loosely correlated | +3.34% | ||
| ELV - CVS | 35% Loosely correlated | -0.49% | ||
| ALHC - CVS | 21% Poorly correlated | -2.89% | ||
| CLOV - CVS | 21% Poorly correlated | -2.77% | ||
More | ||||